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Acute pancreatitis is being encountered more often in children due to antiinetabolite ther-
apy, accidental injury, and traumatic battering. Pancreatitis may occur in the absence of tra-
ditionally elevated serum amylase and lipase, and initial diagnosis may depend uponl ultra-
sonography. Traditional therapy ofenteric rest with nasogastric suctioin has been supported by
the use of parenteral nutrition. Newer pharmaceutical agents have been ineffective in altering
the course of the illness or in preventing complications of pseudocyst or abscess.
PANCREATITIS
Acute pancreatitis is one of the major abdominal catastrophes of all age
groups [1-27]. Once considered unusual in children, the disease is being seen with in-
creasing frequency, and most pediatric centers now treat five to ten acute cases per
year. The increase in the incidence ofthe disease from apreviously reportedfigure of
1 in 500,000 children is due not only to better recognition, but also to a rise in the
number of infants and children subjected to blunt abdominal trauma and to the use
of therapeutic agents which may cause pancreatitis.
Etiology
In approximately one-third of patients no cause for the disease is identified.
However, trauma is now responsible for 30 to 40 percent of the cases of acute pan-
creatitis seen in children, asignificant rise from figures of 13 and 15 percent reported
five to 15 years ago. Abdominal trauma is most often caused by bicycle or sledding
injuries, but is now being recognized in infants subjected to parental battering [8,9].
The pancreas lies fixed in the epigastric region behind the stomach and duodenum
and anterior to the vertebrae. Its consistency is soft and its vascular supply lush, all
rendering it susceptible to injury by a sharp or blunt blow projected to the upper ab-
domen. The poorly developed abdominal wall musculature and small anterior-
posterior diameter ofthe abdomen in children increases the risk ofpancreatic injury
over that in the adult. Such trauma may cause contusion, laceration, or complete
transection of the pancreas.
At the Yale-New Haven Hospital, drug-related pancreatitis is the second most
common cause of the illness (30 percent) in children. L-asparginase, used primarily
for the treatment of leukemia, has caused the most fulminant disease. The onset
may occur days to weeks after initiation of therapy or up to several weeks after its
termination [13]. Valproic acid, used increasingly for the treatment of seizures,
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causes not only hepatitis, but pancreatitis. Similarly, chlorthiazide and related thia-
zides have caused pancreatitis. Steroids are often implicated in the etiology of pan-
creatitis, and, in a review by Jordan and Ament [5], they were responsible for 20 per-
cent of their cases. Steroid-induced pancreatitis occurs twice as often in boys as in
girls and usually follows a change in dosage in either an upward or downward direc-
tion [12]. Focal pancreatic lesions may be found in patients taking steroids who have
no clinical signs of pancreatitis. Pathologic lesions in patients with steroid-induced
pancreatitis have been epitheloid proliferation of the ducts, inspissated secretions,
and dilated atrophic acinai. Ethanol abuse, the most common cause of pancreatitis
in the adult, is an unusual factor in the child, but has been reported to have caused
pancreatitis in one 12-year-old Brazilian boy [14]. With the early use of alcohol in
adolescents, it will undoubtedly be recognized more often as a causative agent. Other
drugs causing pancreatitis are listed in Table 1. The mechanism of drug-induced
pancreatitis remains unknown, although speculation exists as to the possibility of
the drug binding to macromolecules on the pancreatic cell membranes, resulting in
cell death.
Anatomic malformations contribute to the cause of pancreatitis in 10 to 15 per-
cent of the patients by causing obstruction to pancreatic flow [27]. The most com-
mon anatomic lesion is stenosis or hypertrophy of the sphincter of Oddi. Other
causes are impaction of the pancreatic duct by gall stones or obstruction of the duct
by an annular pancreas or choledochal cyst. Four percent of individuals with pan-
creas divisum (non-fusion of the dorsal and ventral ducts) develop pancreatitis,
which is due in the majority to stenosis at the orifice of the dorsal duct [24,25].
Treatment by sphincteroplasty is successful in fewer than 60 percent, suggesting that
this anomaly in many patients may be only coincidental. An extremely rare cause of
pancreatitis is an intrapancreatic duplication cyst of duodenal or gastric origin. An
infectious origin is presumed likely in infants with pancreatitis because gram-nega-
tive organisms have been isolated from nearly two-thirds of affected patients [11].
Mild pancreatitis is not unusual in patients with systemic viral infections and may be
found in up to 15 percent of those with mumps. Epigastric pain and vomiting occur
four to five days after the onset of the parotid swelling or may rarely be only clinical
manifestations of mumps infection [18]. It is of interest that diabetes mellitus has
been reported in children who have had earlier evidence of mumps, coxsackie, or
rubella infection [21]. Pancreatitis has also been associated with infection by adeno-
virus, reovirus, echovirus, and mycoplasma virus pneumoniae [17-19]. Interstitial
pancreatitis has been reported in an infant who died from congenital rubella syn-
drome. Reye's syndrome, when accompanied by clinical and laboratory findings of
pancreatitis, carries an extremely poor prognosis, for the pancreatitis is usually
hemorrhagic in type [20].
The metabolic causes are multiple [1,4,11]. Hyperlipoproteinemia of types I, IV,
and V may be associated in up to 8 percent with acute pancreatitis. Usually the lipid
levels are well above 1,000 mg/ml, but during the acute attack the serum amylase
may be normal. Cystic fibrosis, an inherited disorder which is usually characterized
by pancreatic insufficiency as well as respiratory symptoms, may at times present
with or have concomitant acute pancreatitis [15]. This inflammatory lesion often
develops in adolescents and in those with a milder form of the disease. Hyperpara-
thyroidism, although rare, may cause pancreatitis in children and often is associated
with an intraductal calculus.
Vascular diseases such as the hemolytic-uremic syndrome and systemic lupus
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TABLE 1
Causes of Pancreatitis
A. Traumatic
B. Drug-induced
C. Infection
D. Metabolic
E. Anatomic defect
F. Hereditary
G. Vascular disease
Corticosteroids
Chemotherapeutic agents (i.e., L-asparginase)
Valproic acid
Chlorthiazides
Azulfidine
Alcohol
Ethacrinic acid
Furosemide
Azothioprine
Oral contraceptives
Tetracycline
Cimetidine
Dilantin hypersensitivity
Mumps
Measles
Post varicella
Rubella
Hepatitis A and B
Influenza A
Coxsackie B
Mycoplasma pneumoniae
Leptospirosis
Ascaris
Hydatid cyst
Reye's syndrome
Hyperlipoproteinemia type I, IV, and V
Cystic fibrosis
Hyperparathyroidism
Refeeding after fasting
Uremia
Vitamin A or D deficiency
Glycogen storage disease type I
Scorpion bites
Pancreas divisum (?)
Choledochal cyst
Anomalous insertion of bile duct
Duodenal duplication cyst
Ductal stenosis of sphincter of Oddi
Annular pancreas
Cholelithiasis
Posterior perforation of peptic ulcer
Vasculitis
Hemolytic-uremic syndrome
Systemic lupus erythematosus
H. Idiopathic
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erythematosus may demonstrate pancreatitis as part of their clinical spectrum [26].
Accidental hypothermia has caused intravascular coagulation and pancreatitis [22].
Refeeding pancreatitis is no longer a rare entity and has been noted in athletes,
particularly wrestlers who diet to attain a low weight and who eat heavily after a
match. Recently it has been reported in anorectics who are force-fed a high caloric
diet [16]. Speculation exists as to whether these patients may have a relatively mild
ductal stenosis or obstruction which has been accentuated by a sudden outpouring
of enzymes.
Hereditary pancreatitis occurs in an autosomal dominant pattern with attacks or
recurrent abdominal pain having their onset between infancy and adolescence [11,23].
In a number of patients, stenosis of the sphincter of Oddi has been identified at
surgery or at radiologic examination. After repeated attacks of acute pancreatitis,
there is eventual calcification in the pancreas. An inconstant amino acid urea with
lysine and cystine is found in those from American families and taurine in those
from English ones. Other amino acid ureas consist oflysine, cystine, and arginine or
histidine. One kindred had hemorrhagicphenomena and increased sweat electrolytes
without other signs compatible with cystic fibrosis.
Pathogenesis and Pathophysiology
The pathophysiology of pancreatitis includes three critical ingredients: (1) disrup-
tion ofacinar or ductal integrity, (2) leakage ofpancreatic enzymatic secretions into
tissue spaces, and (3) activation ofproteolytic and lipolytic enzymes. Although gross
descriptions of the pancreas at laparotomy describe edematous, necrotizing, or
hemorrhagic pancreatitis, autopsy examinations present terminology such as
hemorrhagic, necrotizing, suppurative, edematous, or interstitial pancreatitis [6]. It
is best to consider pancreatitis in terms of interstitial, hemorrhagic, or necrotizing.
Interstitial pancreatitis, the milder form associated with fewer complications, is
characterized by inflammation, edema, proliferation of fibroblasts, and collagen
deposition within acinai. There is little necrosis and only isolated areas of fat necro-
sis. The disease is mild, usually associated with viral infections and persists for two
to three days' duration. Hemorrhagic pancreatitis, on the other hand, is severe and
the entire pancreas or large areas of it become necrotic and hemorrhagic with
destruction of normal architecture. Jaundice and hyperbilirubinemia are secondary
to spasm of the sphincter of Oddi. Ascites and pleural effusion may develop during
the acute attack.
The direct release of enzymes from pancreatic damage causes autodigestion ofthe
organ itself [28-32]. Those enzymes entering the peritoneal cavity digest protein and
fat components to contribute to peritonitis. Hematologic and lymphatic spread of
these same components is responsible for the systemic complications ofpancreatitis
[28,29]. Fat necrosis secondary to circulating pancreatic lipase has been described
and causes tender erythematous subcutaneous nodules, polyarthritis, fever, eosin-
ophilia, soft tissue swelling, and bone pain. Bone lesions associated with intra-
medullary fat necrosis may be seen on skeletal roentgenograms and occur in 10.4
percent of cases [30]. There is medullary fat necrosis, cortical destruction, and new
periosteal bone formation. The lesions are best seen in the short bones ofthe hands
and feet. Fat embolism may also occur during acute pancreatitis and cause signifi-
cant morbidity. The syndrome ofpancreatic encephalopathy presenting with mental
confusion, muscle spasm, seizure activity, restlessness, combativeness, stupor, or
coma have been attributed to cerebral fat embolization [31].
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Acute renal failure associated with pancreatitis may be secondary to refractory
hypovolemia, or to fat emboli which cause ischemic, aseptic necrosis with tubular
atrophy and interstitial fibrosis [321.
The primary cause of early death is refractory hypotension which progresses to ir-
reversible shock and organ failure. This is due to massive losses ofblood and plasma
caused by autodigestion of blood vessel walls. The situation is further aggravated by
action of vasoactive peptides activated by kallekrein which is released into the lym-
phatics and plasma. Abnormalities oftheclotting system may occur during the acute
phase of acute pancreatitis, and disseminated intravascular coagulation has been
demonstrated in many patients dying of severe necrotizing pancreatitis. The local
release of trypsin has been shown to activate the clotting sequences.
Patients with severe pancreatitis are often hypocalcemic, but tetany or other clini-
cal manifestations are rarely present. Hypocalcemia is often attributed to binding of
calcium in areas of fat necrosis, but recently data have suggested alterations in levels
of serum calcitonin and/or glucagon as the primary cause. A low serum calcium in
acute pancreatitis may be associated with a low serum albumin and therefore values,
when corrected, are usually normal. In one recent series, hypocalcemia, seen in 67
percent of patients, dropped to 11 percent when appropriately corrected for serum
albumin levels.
Respiratory insufficiency is a significant cause of morbidity, although it is often
undetectable early in the course of disease [33]. It may increase rapidly in severity
and lead to sudden death. The factors most commonly implicated in its pathogenesis
are abdominal distention, pain and guarding, retroperitoneal edema, elevation of
the diaphragm, and pleural effusions. Pleural effusions occur in up to 20 percent of
all patients with acute pancreatitis. They are usually located in the left chest and are
often hemorrhagic. Diffuse pulmonary disease occurs in the more severely ill pa-
tients and in the presence of true persistent hypocalcemia. This syndrome often
manifests itself within one week after onset of pancreatitis and leads to rapidly in-
creasing dyspnea, cyanosis, and hypoxemia. It has been reported to occur in ap-
proximately 1 percent ofall affected patients and may be associated with a mortality
near 50 percent. The etiology remains obscure, but fluid load, aspiration, hypoten-
sion, hypoalbuminemia, fat embolization, and a direct effect on the vasculature or
its permeability have all been suggested as etiologic factors.
Symptoms
Although severe traumatic pancreatitis may present immediately after injury with
the patient in shock and having a rigid abdomen, the symptoms are usually more in-
sidious and the diagnosis may not be considered until clinical deterioration occurs.
Often, traumatic pancreatitis may present weeks after an injury, with the individual
having no recollection of direct trauma. Pain is the major presenting symptom and
occurs in more than 90 percent ofpatients with acute pancreatitis. The pain is often
excruciating and accompanied by nausea and vomiting. It may, however, vary in
character, being mild or severe, constant or intermittent, unrelieved by vomiting.
The children often lie quietly on their sides with their knees flexed. The physical
findings do not always correlate with the severity of the underlying disease. Tachy-
cardia is usually present and the abdomen is distended and tender to palpation.
Bowel sounds, which are present early, may disappear with the development ofileus.
There is usually some guarding in the epigastrium and the patient may describe pain
radiating into the back. A rigid abdomen is rare unless the pancreatitis is accom-
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panied by a visceral perforation or severe intrapancreatic hemorrhage. The
cutaneous signs of acute pancreatitis are seen infrequently: these include early mor-
billiform rashes secondary to subcutaneous fat necrosis, livido reticularis, Turner's
sign (a bluish discoloration of the flanks due to fat necrosis or seepage of blood-
stained fluid into the subcutaneous tissue), and Cullen's sign (a similar bluish dis-
coloration in the periumbilical area).
Diagnosis
Immediate diagnostic tests are an elevated serum amylase and lipase. The serum
amylase is normally less than 150Ag/dl and lipase less than 1.5 units/ml. The serum
amylase is elevated in 95 percent of patients with acute pancreatitis but may be
elevated in other conditions: i.e., macroamylasemia, intestinal obstruction, ovarian
pathology, mumps, parotid or salivary gland lesions, renal insufficiency, hepatitis,
perforations of the small bowel, or acute appendicitis [34-36]. The serum amylase
rises within several hours after the onset of symptoms and returns to normal in
several days. The urinary amylase level (normal, 300 units/hour) remains elevated
for at least one week after an attack and can be used to document disease after
serum values have fallen. Urinary amylase/creatinine clearance may be helpful in
distinguishing the patient with pancreatitis, as a ratio greater than 6.5 percent is sug-
gestive of acute pancreatitis. False negatives can occur in renal failure and false
positives have been reported in diabetic ketoacidosis, in fulminant alcoholic liver
disease, and in burn patients. This test is not infallible and its value is now contro-
versial. The serum lipase rises approximately 24 hours after symptoms are present
and remains elevated for about ten days. Elevations above 1.5 units correlate with
true pancreatitis. The degree of elevation of either enzyme does not correlate with
the severity of the disease or its prognosis.
Anemia may denote a severe hemorrhagic pancreatitis and is not present in mild
disease. A fall in hematocrit of greater than 10 points during the initial 48 hours is
correlated with a poor prognosis [37,38]. Hemoconcentration may occur secondary
to fluid loss. Leukocytosis between 10,000 and 30,000 wbc/cm3 with a shift to im-
mature polymorphonuclear leukocytes is commonly seen. A leukocyte count greater
than 16,000 wbc/cm3 may be associated with increased morbidity. Prolonged leuko-
cytosis and fever indicate abscess or another infectious complication [39]. The
erythrocyte sedimentation rate is elevated in half of the patients.
Hyperglycemia may be present in the acute stage, although some patients are
hypoglycemic. Hypercalcemia, as noted earlier, is frequent. Hyperlipemia is due to
several factors: decreased plasma lipoprotein lipase activity, increase in serum
glycerides, and absorption of fat from intraperitoneal fat necrosis. Abdominal films
of the abdomen may show (1) localized ileus with "sentinel loop," a loop of dilated
jejunum in the mid-epigastrium or left upper quadrant adjacent to the pancreas; (2)
"colon cut-off sign" representing distention of the transverse colon with collapse of
the descending colon in areas adjacent to the pancreatic inflammation; (3) duodenal
distention with occasional air fluid levels or duodenal edema. Other findings are loss
of the psoas shadow, distortion or greater curvature of the stomach, colonic dilata-
tion, or increased epigastric soft tissue density. Calcification of the pancreas is
evidence of earlier attacks of acute pancreatitis. Ultrasonography of the pancreas
has been the procedure of choice as a non-invasive, diagnostic aid in the assessment
of acute pancreatitis [40-43]. It has proven to be the single most valuable clinical
tool in following the pancreatic size in determining whether or not abscess or
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pseudocyst is developing. Initially, the normal cobble-stoned appearance becomes
more sonolucent as the pancreas becomes edematous. Abscess and pseudocyst are
easily differentiated by their characteristic echo-free appearance. Phlegmons may
appear as areas of pancreatic enlargement with numerous internal echoes reflecting
the solid consistency. The role of modern-day ultrasonography in monitoring the
size of a pseudocyst and in determining the optimal time for surgery cannot be over-
emphasized. Nuclear imaging ofthe pancreas using Se75 is complicated by the adja-
cent liver, which readily incorporates the isotope and has largely been replaced by
ultrasonography or computerized tomography. The latter procedure is associated
with considerable radiation exposure and, although preferable for the detection of
smaller pancreatic lesions, offers no greater advantage over ultrasonography in the
management ofpatients with pancreatitis. Retrograde pancreatic studies are contra-
indicated in the presence of acute disease.
Therapy
The therapy of acute pancreatitis is based upon an understanding of the patho-
physiology involved (Table 2) [39]. Primary goals are (1) maintenance of adequate
circulating intravascular volume, (2) minimization of pancreatic exocrine activity,
and (3) prevention or treatment of complications associated with acute pancreati-
tis [6,11,44-50]. Initially, the patient is fasted and nasogastric suction applied to
reduce vomiting and distention and to decrease secretin release secondary to duo-
denal acidification. Intravenous fluids and/or colloid are administered to maintain
an adequate intravascular volume. The hemoglobin, hematocrit, white blood count,
serum calcium, glucose, and electrolytes are monitored closely, and therapy ad-
justed as indicated. Merperidine or pentazocin are recommended for relief of pain
rather than opiates. There is little evidence to suggest that cimetidine reduces pan-
creatic secretion by inhibiting gastric acid production [45,46]. Anticholinergic drugs
such as atropine have been suggested, but controlled studies have failed to show
their effectiveness. Glucagon, a hormone produced bythe pancreas, has been shown
to suppress pancreatic function when given in sufficient doses, but recent controlled
trials have failed to document any true benefit. The use of prophylactic antibiotics
has been shown not to prevent abscess formation or septic complications [47,48].
Such use may predispose the patient to develop infection by organisms which are
resistant to common antibiotics. In recent years, effort has been directed toward in-
hibiting the actual process of pancreatitis. The most successful of these efforts in
animal models has been with the drug aprotonin. Unfortunately, the drug is effec-
TABLE 2
Therapy for Acute Pancreatitis
1. Fast the patient
2. Maintain adequate intravascular volume
3. Nasogastric suction
4. Analgesia (avoid opiates)
5. Follow metabolic parameters closely:
a. Glucose
b. Calcium
c. Electrolytes
d. Hemoglobin
6. Intravenous alimentation if nutritionally indicated
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tive only if administered prophylactically and seems to have no effect once the pro-
teolytic sequence has begun.
Improvements in elemental nutrition and hyperalimentation have markedly im-
proved the prognosis for a patient with prolonged acute pancreatitis. Oral feeding
should not be reinstituted in the patient until all abdominal tenderness, fever, and
leukocytosis have vanished; ileus has resolved; and serum amylase and lipase levels
have returned to normal. Initial feeding should contain carbohydrate and little, if
any, fat or protein, which stimulate pancreatic secretions. Parenteral lipids should
be withheld until the acute illness has subsided [44].
Pleural effusions may respond to therapeutic taps, and diffuse pulmonary injury
is managed as in any other patient with the respiratory distress syndrome. Aggres-
sive fluid or colloid therapy is usually effective in correcting hypotension, but oc-
casionally patients may require pressor agents. Hypoxemia is more frequent than
believed and occurs even in those with mild disease. Renal, hematologic, central ner-
vous system, or cardiovascular complications require aggressive and supportive
therapy. Since most ofthe severe systemic complications are presumed to be second-
ary to enzyme and vasoactive toxins that have been released from the peritoneal
cavity, it has been postulated that removal of these substances may reduce the mor-
bidity and mortality of acute pancreatitis [49,50]. Experimental and controlled
clinical trials of non-operative peritoneal lavage have had some limited success [6].
Experience with this procedure in children is small and at present it cannot berecom-
mended as a routine measure. Pancreatitis as the result oftrauma may involve actual
anatomic fractures ofthe gland, parenchyma, and/or duct transection. In such cases
simple debridement and drainage are inadequate and subtotal pancreatectomy and
distal drainage are required. Pancreatitis resulting from ampullary obstruction by a
duodenal hematoma will often not resolve until the hematoma is evacuated. Factors
associated with poor prognosis are itemized in Table 3.
Complications
An acute episode ofpancreatitis which persists into the second or third week often
becomes complicated by the formation ofan inflammatory mass in 15 percent ofpa-
tients. With this there are increased abdominal tenderness, elevation oftemperature,
and leukocytosis. The mass may represent a phlegmon, abscess, or pseudocyst
[6,11]. Phlegmons themselves may develop into a well-defined pseudocyst or be-
come secondarily infected to form an abscess. Abscess develops in approximately
TABLE 3
Laboratory Parameters Indicating Poor Prognosis
Admission:
White blood count > 16,000/mm3
Blood glucose > 200 mg/dl
Serum lactic dehydrogenase > 350 IU/L
Serum glutamic oxaloacetic transaminase > 250 u
Duringfirst 48 hours:
Hematocrit fall > 10 points
Blood urea nitrogen rise > 5 mg/dl
Serum calcium < 8 mg/dl
Arterial PO2 < 60 mm Hg
Base deficit > 4 mEq/L
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5 percent ofall patients with acute pancreatitis and carries an associated mortality of
22 to 57 percent. Abscess formation results from secondary infection or necrotic
devitalized tissue and the bacteria recovered in over 90 percent of abscesses are
enteric flora. Antibiotic therapy with external surgical drainage is mandatory. A
pseudocyst consists of collections of blood, pancreatic enzymes, tissue fluid, and
debris from the pancreas and develops within several weeks after the onset of acute
disease [51]. Early, it contains no mature fibrous capsule and may be reabsorbed
(less than 10 percent). The mortality of sudden rupture of a pseudocyst is so high
that medical management should only be attempted when very close observation can
be performed over a period of weeks. Surgical intervention should be attempted
only after the cyst is mature (between six to eight weeks) with the cyst marsupialized
and drained internally to the stomach or duodenum. Uncommonly, major arterial
hemorrhage has been reported secondary to pseudocyst erosion into major arteries
supplying the intestine. Diabetes mellitus has been reported as a late complication of
acute pancreatitis in children who have had prior viral infection. Pancreatic exocrine
insufficiency is uncommon, since this requires destruction of 85 to 90 percent of the
gland.
CONCLUSIONS
The incidence of acute pancreatitis in children is increasing primarily due to a rise
in abdominal trauma and an increase in usage of drugs which are toxic to the pan-
creas. Despite the varied etiologies of pancreatitis, therapy is directed toward
decreasing pancreatic exocrine function and support of the hemodynamic conse-
quences secondary to release of pancreatic enzymes and toxins into the system. Al-
though the course cannot always be correlated with the severity ofdisease in onset, a
number of laboratory findings suggesting a poor prognosis have been identified.
Despite numerous clinical trials with the use of agents considered to be effective in
decreasing the severity ofpancreatitis, none has demonstrated any significant thera-
peutic benefit. Intensive medical management of the patient with the use of intra-
venous or parenteral alimentation and careful scrutiny for the development of surgi-
cal complications remains the primary therapy.
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